Skip to main content

UBS Group AG

Position in ATXI — Avenue Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ATXI

as of Dec 31, 2024 · filed Feb 14, 2025
Position Value
$15,840
+$544 QoQ
Shares Held
7,920
+28.9% QoQ
Ownership
0.240%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 7 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATXI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ATXI

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2024-12-31 $15,840 7,920
2024-09-30 $15,296 6,143
2024-06-30 $2,355 673
2023-12-31 $173 1,080
2022-12-31 $1,445 1,246
2022-09-30 $11,471 1,138
2022-06-30 $8,575 31,843
2022-03-31 $14,918 30,984
2021-12-31 $24,724 27,230
2021-09-30 $10,327 6,931
2021-06-30 $3,340 1,331
2021-03-31 $34,246 5,642
2020-12-31 $22,907 3,850
2020-09-30 $31,623 2,920
2020-06-30 $68,152 6,328
2020-03-31 $17,880 2,000